2024 -
now Assoc. Principal Scientist, Biomarkers @
2023 -
now Head of Biomarkers @
2021 -
2024 Senior Scientist @
2020 -
2021 Research Scientist @
2014 -
2020 Senior Scientist @ HealthTell
2012 -
2014 Assistant Professor Research @
2007 -
2012 Postdoctoral Scholar @
2006 -
2007 Post Doctoral Researcher @ Naval Medical Research Center, Biological Defense Research Directorate, Vaccine
Bart Legutki Education
The Ohio State University
PhD (Microbiology)
1999
-
2006
Loyola University Chicago
Bachelor of Science (BS) (Biology, General)
1994
-
1998
Bart Legutki Skills
Assay Development
Immunoassays
Vaccines
Microarray
ELISA
Immunology
Bioinformatics
Microarrays
R
Microarray Analysis
Protein Expression
Proteomics
Protein Purification
Gel Electrophoresis
Molecular Cloning
Fluorescence
PCR
Cell Culture
Western Blotting
Biotechnology
DNA sequencing
Microbiology
Computational Biology
Protein Chemistry
Sequence Analysis
DNA
Purification
Molecular Biology
Sequencing
Fluorescence Microscopy
Genomics
Tissue Culture
DNA extraction
Cell Biology
Drug Discovery
Transfection
Chromatography
Cancer
HPLC
Science
Lifesciences
Antibodies
Life Sciences
Medicine
Bart Legutki Summary
Bart Legutki, based in New York, NY, US, is currently a Assoc. Principal Scientist, Biomarkers at InVitro Cell Research, LLC. Bart Legutki brings experience from previous roles at InVitro Cell Research, LLC, Arizona State University and HealthTell. Bart Legutki holds a 1999 - 2006 PhD in Microbiology @ The Ohio State University. With a robust skill set that includes Assay Development, Immunoassays, Vaccines, Microarray, ELISA and more. Bart Legutki has 2 emails and 1 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.